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Clinical findings
An 88-year-old woman was admitted with a huge
bilateral pulmonary embolism and acute renal failure.
On physical examination, a well-defined irregularly
pigmented plaque 20 · 40 mm with black, brown and
pink hues and an irregular border was noticed over the
umbilicus (Fig. 1). A clinical diagnosis of malignant
melanoma (MM) was suggested, and surgical excision
planned. However, the patient’s prognosis was poor; she
was very dyspnoeic, with oxygen saturation levels of
< 75%, despite the treatment for pulmonary embolism,
thus we chose to perform a biopsy to confirm the
diagnosis, with the intention to proceed to treatment
once the patient recovered from the embolism.
Histopathological findings
On histological examination, a full-thickness intra-
epidermal proliferation of atypical keratinocytes with
overlying parakeratosis was seen, characterized by
disordered maturation, mitosis at different levels of the
epidermis, and focal dyskeratosis (Fig. 2). Strikingly, the
atypical keratinocytes contained variable amounts of
melanin granules. Melanophages also occurred focally
in the underlying dermis.
What is your diagnosis?
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Figure 1 Pigmented Bowen disease over the umbilicus; (b) close-
up view.
Figure 2 Intraepidermal proliferation of atypical keratinocytes,
parakeratosis, disordered maturation, mitosis and focal dyskera-
tosis. Atypical keratinocytes contained variable amounts of mela-
nin granules. Haematoxylin and eosin, original magnification ·
200.
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Diagnosis
Pigmented Bowen disease (PBD).
Discussion
PBD is a rarely diagnosed cutaneous intraepidermal
neoplasm that may be clinically difficult to distinguish
from MM. It is a type of in situ squamous cell carcinoma
(SCC), a malignant epithelial tumour, which presents as
a slowly enlarging, pinkish, scaly plaque, and can affect
both the skin and mucosa of older adults, especially
women. In addition to exposure to ultraviolet radiation,
other aetiological factors for SCC, have been suggested,
including chemicals (e.g. arsenic), immunosuppression
and human papillomavirus infection. Only about 5% of
all cases of BD are pigmented1, and the condition is
described more frequently in dark-skinned people.
Unlike most types of in situ SCC, which occur mainly
on sun-exposed areas, PBD is more likely to occur on
sun-protected areas. In a recent retrospective analysis of
52 cases of PBD, Cameron et al. 1reported PBD as
presenting most frequently as a flat or slightly raised,
light-brown plaque, with varying degrees of scaling,
occurring more often in men, on the limbs, trunk, head
and neck. To our knowledge, there have only been two
previous reports of PBD of the umbilicus.2,3
It is not fully understood why pigment deposition
occurs. Some authors have suggested that neoplastic
cells might produce specific cytokines that induce
proliferation of melanocytes and production and trans-
fer of melanin to the atypical keratinocytes,4 whereas
others have suggested an association with solar lenti-
gines and seborrhoeic keratoses.1,5 We did not find any
histological evidence of these in our patient.
Clinically, PBD mimics other pigmented lesions such
as seborrhoeic keratoses, pigmented actinic keratosis,
solar lentigo, melanocytic naevi, pigmented basal cell
carcinoma and MM, as in our patient. Various derma-
toscopic features of PBD have been described but,
according to Cameron,1 although a structureless
pattern was the most common, the pattern of a linear
arrangement of brown and ⁄ or grey dots and ⁄ or coiled
vessels was more specific.
The presence of pigment does not change the prognosis
or treatment of BD, so treatment options include those
indicated for nonpigmented BD: surgery, cryotherapy,6
laser ablation, topical imiquimod or 5-fluorouracil,
curettage, electrosurgery and photodynamic therapy.3
PBD generally has a good prognosis; unfortunately, in
this case, the patient’s general condition was poor. We
treated her with optimum anticoagulant therapy for the
embolism, but her condition quickly deteriorated and she
died 3 days later.
In conclusion, we report a patient presenting with a
lesion that clinically was suggestive of MM. Unexpect-
edly, however, the histopathological finding identified
the lesion as being a PBD. In general, the good prognosis
of PBD permits a more conservative and cost-effective
therapeutic approach of the lesion.
Learning points
• Only about 5% of all cases of BD are pigmented.
• Clinically, PBD presents most often as a flat or
slightly raised, light-brown plaque, with varying
degrees of scaling, occurring more often in men, on
the limbs, trunk, head and neck.
• PBD should be included in the differential
diagnosis of pigmented lesions such as MM.
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